Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients

Renal Failure

Volumn 27, Issue 1, 2005, Pages 59-65

  Tsuchiya, Ken ^a   Saito, Madoka ^a   Okano Sugiyama, Hiroko ^a   Nihei, Hiroshi ^a   Ando, Minoru ^b   Teramura, Masanao ^a   Iwamoto, Yu Suke ^c   Shimada, Katsunori ^d   Akiba, Takashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c Saito Animal Hospital   (Japan)

^d STATZ Institute Inc   (Japan)

Author keywords

Anemia; Chronic renal failure (CRF); Erythropoietin (EPO); Recombinant human erythropoietin (rHuEPO); Reticulocyte hemoglobin

Indexed keywords

CREATININE; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RENAL ANEMIA; RETICULOCYTE; TRANSFERRIN BLOOD LEVEL;

ANEMIA, IRON-DEFICIENCY; DISEASE PROGRESSION; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETICULOCYTES;

EID: 13144307193     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-42792     Document Type: Article

References (32)

1. Eschbach, J.W.; Egrie, J.C.; Downing, M.R.; Browne, J.K.; Adamson, J.W. Correction of the anemia of end stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. N. Engl. J. Med. 1987, 316, 73-78.
2. Evans, R.W.; Rader, B.; Manninen, D.L. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 1990, 263, 825-830.
3. Frankenfield, D.; Johnson, C.A.; Wish, J.B.; Rocco, M.V.; Madore, F.; Owen, W.F. Anemia management of adult hemodialysis patients in the US: results from the 1997 ESRD Core Indicators Project. Kidney Int. 2000, 57, 578-589.
4. Roth, D.; Smith, R.D.; Schulman, G.; Steinman, T.I.; Hatch, F.E.; Rudnick, M.R.; Sloand, J.A.; Feedman, B.I.; Williams, W.W., Jr.; Shadur, C.A.; Benz, R.L.; Teehan, B.P.; Revicki, D.A.; Sarokhan, B.J.; Abels, R.I. Effect of recombinant erythropoietin on renal function in chronic renal failure predialysis patients. Am. J. Kidney Dis. 1994, 24, 777-784.
5. Jungers, P.; Choukroun, G.; Oualim, Z.; Robino, C.; Nguyen, A.T.; Man, N.K. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol. Dial. Transplant. 2001, 16, 307-312.
6. Van Wyck, D.B.; Stivelman, J.C.; Rutz, J.; Kirlin, L.F.; Katz, M.A.; Ogden, D.A. Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int. 1989, 35, 712-771.
7. Macdougall, I.C. Poor response to erythropoietin should be fully investigated and treated. Br. Med. J. 1995, 310, 1424-1425.
8. Besarab, A.; Amin, N.; Ahsan, M.; Vogel, S.E.; Zazuwa, G.; Frinak, S.; Zazra, J.J.; Anandan, J.V.; Gupta, A. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J. Am. Soc. Nephrol. 2000, 11, 530-538.
9. Brugnara, C.; Hipp, M.J.; Irving, P.J.; Lathrop, H.; Lee, P.A.; Minchello, E.M.; Winkelman, J. Automated reticulocyte counting and measurement of reticulocyte cellular indices: evaluation of the Miles H*3 blood analyzer. Am. J. Clin. Pathol. 1994, 102, 623-632.
10. Kuriyama, S.; Tomonari, H.; Yoshida, H.; Hashimoto, T.; Kawaguchi, Y.; Sakai, O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 1997, 77, 176-185.
11. National Kidney Foundation, DOQI (dialysis outcomes quality initiative) clinical practice guidelines - anemia of chronic renal failure. Am. J. Kidney Dis. 1997, 30 (Suppl. 3), S194-S237.
12. Astro, B.C.; Muntner, P.; Levin, A.; Eustace, J.A.; Coresh, J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1944). Arch. Intern. Med. 1992, 162, 1401-1408.
13. Kazmi, W.H.; Kausz, A.T.; Khan, S.; Abichandani, R.; Ruthazer, R.; Obrador, G.T.; Pereira, B.J. Anemia: an early complication of chronic renal insufficiency. Am. J. Kidney Dis. 2001, 38, 803-812.
14. Hsu, C.Y.; McCulloch, C.E.; Curhan, G.C. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J. Am. Soc. Nephrol. 2002, 13, 504-510.
15. Jungers, P.Y.; Robino, C.; Choukroung, G.; Nguyen-Khoa, T.; Massy, Z.A.; Jungers, P. Incidence of anemia and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients. Nephrol. Dial. Transplant. 2002, 17, 1621-1627.
16. Madore, F.; Lowrie, E.G.; Brugnara, C.; Lew, N.L.; Lazarus, J.M.; Bridges, K.; Owen, W.F. Anemia in hemodialysis patients: variables affecting this outcome predictor. J. Am. Soc. Nephrol. 1997, 8, 1921-1929.
17. Van Hove, L.; Goossens, W.; Van Duppen, V.; Verwilghen, R. Reticulocyte count using thiazole orange. A flow cytometric method. Clin. Lab. Hematol. 1990, 12, 287-289.
18. Schaefer, R.M.; Schaefer, L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rHuEPO therapy. J. Perinat. Med. 1995, 23, 83-88.
19. Bovy, C.; Tsobo, C.; Crapanzano, L.; Rorive, G.; Beguin, Y.; Albert, A.; Paulus, J.M. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney Int. 1999, 56, 1113-1119.
20. Cullen, P.; Soffker, J.; Hopfl, M.; Bremer, C.; Schlaghecken, R.; Mehrens, T.; Assmann, G.; Schaefer, R.M. Hypochromic red cells and reticulocyte hemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic hemodialysis. Nephrol. Dial. Transplant. 1999, 14, 659-665.
21. Skikne, B.S.; Flowers, C.H.; Cook, J.D. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990, 75, 1870-1876.
22. Ferguson, B.J.; Skikne, B.S.; Simpson, K.M.; Baynes, R.D.; Cook, J.D. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J. Lab. Clin. Med. 1992, 19, 385-390.
23. Daschner, M.; Mehls, O.; Schaefer, F. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients. Clin. Nephrol. 1999, 52, 246-252.
24. Fishbane, S.; Galgano, C.; Langley, R.C., Jr.; Canfield, W.; Maesaka, J.K. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int. 1997, 52, 217-222.
25. Mittman, N.; Sreedhara, R.; Mushnick, R.; Chattopadhyay, J.; Zelmanovic, D.; Vaseghi, M.; Avram, M.M. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am. J. Kidney Dis. 1997, 30, 912-922.
26. Tsuchiya, K.; Okano, H.; Teramura, M.; Iwamoto, Y.; Yamashita, N.; Suda, A.; Shimada, K.; Nihei, H.; Ando, M. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin. Nephrol. 2003, 59, 115-123.
27. Fishbane, S.; Lynn, R.I. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients. Clin. Nephrol. 1995, 44, 238-240.
28. Silverberg, D.S.; Iaina, A.; Peer, G.; Laplan, E.; Levi, B.A.; Frank, N.; Steinbruch, S.; Blum, M. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am. J. Kidney Dis. 1996, 27, 234-238.
29. Dahdah, K.; Patrie, J.T.; Bolton, W.K. Intravenous iron dextran treatment in predialysis patients with chronic renal failure. Am. J. Kidney Dis. 2000, 36, 775-782.
30. Vanrenterghem, Y.; Barany, P.; Mann, J.F.E.; Kerr, P.O.; Wilson, J.; Baker, N.F.; Gray, S.J. Randomized trial of Dar epoetin alfa for treatment of renal anemia at a reduced dose frequency compared trial of Dar epoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int. 2002, 62, 2167-2175.
31. Hoen, B.; Kessler, M.; Hestin, D.; Mayeux, D. Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicenter prospective survey. Nephrol. Dial. Transplant. 1995, 10, 377-382.
32. Kletzmayr, J.; Horl, W.H. Iron overload and cardiovascular complications in dialysis patients. Nephol. Dial. Transplant. 2002, 17 (Suppl. 2), 25-29.